TO
Theriva Biologics, Inc.
TOVX · AMEX
$0.23 +1.34% (+$0.00)
1M -1.83%
Market Cap $10.9M
P/E Ratio -
Div. Yield -
ROE 93.49%
Bulios Fair Price
$0.14
40.1% downside
Trenutna cena
$0.23
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica TOVX trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
50 /100
Fair P/B 0.89x
P/S 36.22x
EV/EBITDA N/A
Growth
0 /100
Declining Book val. growth 34.43%
Rev. growth N/A
FCF growth N/A
Profitability
20 /100
Weak Net margin 3,872.67%
Op. margin 3,966.00%
FCF margin 4,125.00%
Quality
0 /100
Poor ROE 93.49%
ROA 33.33%
Asset turnover 0.01x
Debt
82 /100
Low Current ratio 1.13x
Debt/Equity 0.29x
Net debt/EBITDA N/A
Stability
48 /100
Moderate EPS volatility 39.49%
Profitable years 0
Beta 1.15x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o TOVX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Steven A. Shallcross
Employees
16
Headquarters
Rockville
Prihajajoči dogodki
17 NOV.
Earnings
Upcoming earnings report